GLP-1 before surgery: 5 SuperPATH Questions

A conversation about GLP-1 before surgery belongs in your SuperPATH preparation, whether you take the medication for type 2 diabetes, weight management, or both. These medicines can affect stomach emptying, blood glucose, appetite, and how your body responds around anesthesia.

SuperPATH is a minimally invasive hip replacement approach, but hip replacement is still major surgery. Your surgeon, anesthesia clinician, and prescribing provider need accurate information before they create your plan. These five questions can help you prepare for that conversation.

1. Why does GLP-1 before surgery matter for SuperPATH?

GLP-1 receptor agonists can slow the movement of food from your stomach into your intestine. That effect may help control appetite and blood sugar, but it also matters when anesthesia is involved. A person may have more stomach contents than expected, even after following standard fasting instructions.

Common medications in this group include semaglutide, tirzepatide, liraglutide, dulaglutide, and oral semaglutide. Brand names include Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, Saxenda, Trulicity, and Rybelsus.

SuperPATH changes the surgical approach

SuperPATH uses a smaller working corridor near the back of the hip and aims to preserve more of the surrounding soft tissue. Some patients may have less early muscle disruption and a shorter initial recovery, depending on their health and surgical plan.

However, a smaller incision doesn't remove the need for careful medical preparation. You may still receive spinal anesthesia with sedation, general anesthesia, or another combination selected for your health and procedure. You can review anesthesia options for SuperPATH hip replacement before your consultation.

The medication affects more than anesthesia

GLP-1 medicines also affect blood-glucose control. If you take one for diabetes, stopping it without a replacement plan could raise your glucose before or after surgery. High or low blood sugar can affect hydration, energy, infection risk, and recovery.

That creates a balance. The team must reduce anesthesia risks while maintaining safe metabolic control. Your reason for taking the medication, dose, schedule, recent changes, and other treatments all help determine the safest approach.

2. Should you stop GLP-1 before surgery?

There isn't one rule that applies to every patient. The current U.S. guidance is risk-based. An ASA-led multi-society guidance released on October 29, 2024, states that most patients can continue GLP-1 medications before elective surgery when their care team finds no elevated-risk concerns.

That guidance came from the American Society of Anesthesiologists, American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons.

Why older instructions may look different

The ASA's 2023 consensus guidance suggested holding daily GLP-1 medicines on the day of surgery and weekly medicines for seven days before surgery. Many patients still see those intervals online or hear them from another medical office.

The newer guidance does not require every patient to follow those hold times. Instead, the surgical team weighs delayed stomach emptying against the need for diabetes and weight-management treatment. Your surgeon and anesthesia clinician may follow a different plan based on your medication and health history.

Never change the schedule on your own

Don't skip, delay, double, or restart a dose based on general advice from the internet or another person's surgery. Contact the surgical team if you aren't sure what to do, especially if your procedure is approaching.

Your team may ask about:

• The medication name and whether it is daily or weekly
• Your current dose and the date of your last dose
• Whether you recently started treatment or increased the dose
• Why you take it, such as diabetes or weight management
• Any insulin, metformin, sulfonylurea, or other diabetes treatment
• Nausea, vomiting, abdominal pain, bloating, or early fullness

A written medication plan should be part of your preoperative clearance for SuperPATH surgery. If your instructions aren't clear, ask for confirmation before surgery day.

3. Which symptoms should you report before SuperPATH?

New or worsening digestive symptoms can change the anesthesia plan. Tell your surgical team about nausea, vomiting, abdominal pain, abdominal swelling, or an inability to keep fluids down. These symptoms may suggest that your stomach is emptying more slowly.

Contact the team even if the symptoms seem mild or started several days before surgery. The decision to proceed depends on the severity, timing, your medication, and the type of anesthesia planned.

Vomiting and dehydration need prompt attention

Repeated vomiting can cause dehydration and disturb electrolytes. You may also have difficulty controlling your blood glucose if you can't eat, drink, or take other medicines normally.

Call the surgical office or follow the facility's urgent instructions if you have:

• Persistent vomiting or trouble keeping liquids down
• Severe or worsening abdominal pain
• A swollen abdomen with increasing discomfort
• Dizziness, fainting, confusion, or very little urine
• High or low blood-glucose readings outside your usual plan

Don't wait until you arrive at the surgical center to mention these symptoms. The team may need to evaluate you, adjust treatment, or postpone elective surgery until the problem improves.

Dose changes can raise the risk

The risk of digestive side effects may be higher when you first start a GLP-1 medication, increase the dose, or take a higher dose. Tell your care team if any of these apply to you.

Some people notice early fullness without severe symptoms. That detail still belongs in your medication discussion. Your anesthesia clinician will decide whether your symptoms require extra precautions.

A 24-hour liquid-only diet may be recommended for selected higher-risk patients. Follow it only when your surgical team gives that instruction, and ask what liquids and diabetes adjustments are appropriate for you.

4. How can GLP-1 affect anesthesia and aspiration risk?

Delayed stomach emptying can leave food or liquid in the stomach despite normal fasting. Under anesthesia, stomach contents can move back toward the throat and enter the lungs. This event is called aspiration.

The concern is greatest with general anesthesia, but it doesn't disappear with spinal anesthesia. A patient may receive sedation, need airway support, or require a change to general anesthesia during a procedure.

General anesthesia requires careful screening

Before surgery, the anesthesia clinician will ask about your last GLP-1 dose, digestive symptoms, fasting, and medical history. If you have symptoms or other risk factors, the team may change the anesthesia plan or delay surgery.

For selected high-risk patients, current guidance includes options such as:

• A liquid-only diet for at least 24 hours before the procedure
• A point-of-care gastric ultrasound before anesthesia
• An anesthesia technique that reduces aspiration risk
• Rapid-sequence induction when general anesthesia is appropriate

These decisions belong to the anesthesia team. A gastric ultrasound isn't needed for every patient, and a medication hold isn't automatically required for every SuperPATH case.

Regional anesthesia still needs a medication review

Spinal or regional anesthesia often lowers the risk associated with airway management compared with general anesthesia. Still, sedation can make you less able to protect your airway. The team also needs a backup plan if anesthesia must be changed.

That is why the same disclosure matters even when your planned SuperPATH procedure uses spinal anesthesia. Bring your medication information to the pre-op visit and repeat any changes on surgery day.

You can also review what to expect on SuperPATH surgery day, including the pre-op medication and anesthesia conversations.

5. How will diabetes treatment be managed around surgery?

If you take a GLP-1 medication for diabetes, the team must consider your glucose plan before deciding whether to continue or pause it. Stopping the medicine may require closer glucose checks or a temporary replacement plan.

The 2024 multi-society guidance emphasizes shared decision-making because the risk of aspiration must be weighed against the risk of poor metabolic control. A prescribing clinician may help adjust other diabetes medicines if a GLP-1 dose is held.

Bring a complete medication record

Write down your current information before your pre-op appointment:

• Medication names, doses, and timing
• The reason for each medication
• Your last GLP-1 dose and the next scheduled dose
• Insulin or other diabetes medicines
• Recent glucose readings, if you monitor them
• Recent nausea, vomiting, abdominal pain, or reduced appetite

Bring the list to your surgeon's office, anesthesia appointment, and surgical facility. Medication bottles or clear photos of the labels can help prevent errors.

The plan may include glucose checks while you are fasting, changes to other diabetes medicines, or instructions for meals and fluids after surgery. Follow the written instructions from your care team rather than trying to create a substitute schedule.

Ask before restarting after surgery

Your postoperative plan may depend on nausea, vomiting, food and fluid intake, kidney function, glucose readings, and the type of diabetes treatment you use. Even if you paused the medication before surgery, don't restart it until the appropriate clinician confirms the timing.

Call the team if you cannot keep fluids down, develop increasing abdominal pain, have repeated vomiting, or notice concerning glucose readings. Dehydration and poor glucose control need attention during the early recovery period.

The same rule applies if you missed a dose, took one earlier than planned, or aren't sure whether you followed the pre-op instructions. Tell the team what happened without trying to correct it yourself.

Conclusion

GLP-1 before surgery requires a personal plan, not an automatic stop order. Most patients may continue treatment under current risk-based guidance, while digestive symptoms, recent dose increases, diabetes needs, and anesthesia type can change the plan.

Tell your SuperPATH team the medication name, dose, timing, reason for use, symptoms, and other diabetes treatments. Clear communication helps the team address aspiration risk, hydration, blood-glucose control, and safe medication changes before you reach the operating room.